• Home
  • About CML
    • Who We Are
    • What we Do
    • Mission & Vision
    • The Patient Advisory Board
  • What is CML
  • Treatments
    • Access
    • Living Well
    • Clinical Trials
  • News
  • Contact
  • Home
  • About CML
    • Who We Are
    • What we Do
    • Mission & Vision
    • The Patient Advisory Board
  • What is CML
  • Treatments
    • Access
    • Living Well
    • Clinical Trials
  • News
  • Contact

CML & COVID-19 Important information

•22 October 2024

COVID vaccine information For CML patients living in Quebec, under the age of 60

Statement from the iCMLf for people with CML and COVID-19 Vaccines

Read the Expert Panel statement and important advice on CML & COVID-19

If you are a CML patient and you have tested positive for COVID-19, the iCMLf would like to hear from you.

To Visit the COVID-19 HUB of the International CML Foundation

Previous PostCML and COVID – 19 Case CollectionNext PostCanCertainty

Related Posts

ACCESS TO AFFORDABLE MEDICINE FOR ALL

CML Access to Medicine

APO-IMATINIB

Apo – imatinib – Treatment for CML



CML Society of Canada provides support, education and information on CML, current and emerging treatments and research initiatives for people living with CML and their families.

Contact Centre

1 (514) 239-5488

All Across Canada

Mon – Fri: 8.00am 6.00pm

Member Resources

  • About CML
  • What is CML
  • Contact Us
  • Treatments
  • News
  • Videos

Our Newsletter

Copyright ©2024 CML. All Rights Reserved. Legal and Privacy.